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ABSTRACT
Tagging a protein of interest with GFP using genome editing is a
popular approach to study protein function in cell and developmental
biology. To avoid re-engineering cell lines or organisms in order to
introduce additional tags, functionalized nanobodies that bind GFP
can be used to extend the functionality of the GFP tag. We developed
functionalized nanobodies, which we termed ‘dongles’, that could
add, for example, an FKBP tag to a GFP-tagged protein of interest,
enabling knocksideways experiments in GFP knock-in cell lines. The
power of knocksideways is that it allows investigators to rapidly switch
the protein from an active to an inactive state. We show that dongles
allow for effective knocksideways of GFP-tagged proteins in genome-
edited human cells. However, we discovered that nanobody binding
to dynamin-2–GFP caused inhibition of dynamin function prior to
knocksideways. The function of GFP-tagged tumor protein D54
(TPD54, also known as TPD52L2) in anterograde traffic was also
perturbed by dongles. While these issues potentially limit the
application of dongles, we discuss strategies for their deployment
as cell biological tools.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Clathrin-mediated endocytosis, Dynamin, Nanobody,
GFP-binding protein, Knocksideways
INTRODUCTION
Fluorescent proteins revolutionized cell biology. The green
fluorescent protein (GFP) or its relatives can be attached to
virtually any protein of interest and allow the direct visualization
of that protein by light microscopy or flow cytometry (Wang and
Hazelrigg, 1994). Whole genome GFP-tagging projects have been
completed in yeast (Huh et al., 2003), plants (Tian et al., 2004),
bacteria (Kitagawa et al., 2005) and fly (Nagarkar-Jaiswal et al.,
2015). The advent of genome engineering, particularly via
CRISPR/Cas9, has allowed the creation of GFP knock-in
mammalian cell lines in labs around the world (Jinek et al.,
2013), with centralized efforts to systematically tag genes in human
induced pluripotent stem cells (Roberts et al., 2017). While these
resources are incredibly useful, additional tags would further
enhance our ability to probe protein function in single cells.
Of particular interest is the ability to rapidly modulate protein
function. Inducible methods such as relocation (Haruki et al., 2008;
Robinson et al., 2010) and degradation (Nishimura et al., 2009) allow
investigators to study the effect of inactivating a protein of interest in
live cells. For example, we have used the knocksideways method
to study protein function at distinct stages of mitosis, without
perturbing interphase function (Cheeseman et al., 2013). Here, a
protein of interest has an FKBP tag that allows inducible binding to a
mitochondrially targeted protein containing an FRB tag (MitoTrap) via
the heterodimerization of FKBP and FRB by rapamycin (Robinson
et al., 2010). The power of these methods lies in the comparison of the
active and inactive states of the protein of interest.
The development of camelid nanobodies that bind GFP have been
very useful as affinity purification tools (Rothbauer et al., 2008).
Since these nanobodies can be readily expressed in cells, it is
possible to use them as ‘dongles’ to extend the functionality of GFP
by attaching a new protein domain to the GFP-tagged protein of
interest via fusion with the nanobody. This approach has been
exploited to degrade proteins of interest (Caussinus et al., 2011;
Kanner et al., 2017; Daniel et al., 2018; Yamaguchi et al., 2019), to
introduce additional tags (Rothbauer et al., 2008; Ariotti et al., 2015;
Derivery et al., 2017; Zhao et al., 2019), or to constitutively
relocalize GFP-tagged proteins (Schornack et al., 2009; Derivery
et al., 2015). Recently a suite of functionalized nanobodies to GFP
or RFP were generated, enabling recoloring, inactivation, ectopic
recruitment and calcium sensing (Prole and Taylor, 2019). The
dongle approach holds much promise because it is flexible and
saves investigators from re-engineering knock-in cell lines to
introduce additional tags.
Some time ago, we developed dongles to allow knocksideways
experiments in GFP knock-in cell lines. The approach certainly
works and we demonstrate this using two different genome-edited
human cell lines. However, we discovered during the course of
development that nanobody binding to dynamin-2–GFP causes
inhibition of dynamin function, prior to any induced inactivation.
Since the purpose of knocksideways is to compare active and
inactive states, the dongles could not be used in this way. The aim of
this paper is to alert other labs to the possibility that nanobodies
against GFP can perturb the function of the target GFP-tagged
protein. We discuss what strategies investigators might pursue as
alternatives and outline possible applications of dongles despite this
limitation.
RESULTS
Testing fluorescent protein selectivity of dongles in cells
Most experimental applications of dongles would involve two
different fluorescent proteins, one as a target for the dongle and a
second as an experimental readout. We therefore wanted to assess
the fluorescent protein selectivity of the GFP nanobody in cells. ToReceived 31 May 2019; Accepted 3 October 2019
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do this, we used a visual screening method in HeLa cells by
expressing a GFP nanobody (GFP-binding protein enhancer,
GBPen) that was constitutively attached to the mitochondria
(DongleTrap, see Materials and Methods) along with a suite of
twenty-five different fluorescent proteins. Affinity of the fluorescent
protein for the DongleTrap resulted in a steady-state relocation to the
mitochondria, while lack of interaction meant that the fluorescent
protein remained cytoplasmic (Fig. 1). We observed relocation
for mAzurite, EBFP2, sfGFP, mEmerald, EGFP, Clover, EYFP,
mVenus and mCitrine. The following fluorescent proteins remained
cytoplasmic in all cells examined: TagBFP2, ECFP, mCerulean3,
mTurquoise2, mAzamiGreen, mNeonGreen, mOrange2, mKO2,
DsRed, mRuby2, mScarlet, mRFP, mCherry, mNeptune2,
mMaroon and TagRFP657. All of the fluorescent proteins that
DongleTrap binds are derivatives of avGFP (GFP from Aequorea
victoria), while it did not bind proteins from other lineages,
e.g. dsRed, eqFP578, and LanYFP (Lambert, 2019). The GBPen has
further specificity besides lineage, since DongleTrap did not bind
other avGFP descendants ECFP, mCerulean3 and mTurquoise2
(Kubala et al., 2010). These experiments demonstrated which tags
could be manipulated by dongles in cells (e.g. GFP), but also which
fluorescent proteins can be used simultaneously with these tools,
without interference (e.g. mCherry).
Dongles can be used to extend the function of GFP
Knocksideways is a useful tool to rapidly inactivate proteins by
sequestering them onto mitochondria using heterodimerization of
FKBP and FRB domains (Robinson et al., 2010). Typically, the
FKBP domain is fused to the protein of interest (usually along with
GFP for visualization) and the FRB domain is part of MitoTrap
(Fig. 2). To demonstrate the usual application of this method, we
rerouted the membrane trafficking protein tumor protein D54
(TPD54, also known as TPD52L2) to mitochondria (for detailed
analysis of TPD54 rerouting see Larocque et al., 2019). To do this,
Fig. 1. Selectivity of dongles for fluorescent proteins. Representative images of HeLa cells expressing DongleTrap (pMito–GBPen) and the indicated
fluorescent protein. Binding to DongleTrap results in mitochondrial localization of the fluorescent protein and is indicated by a tick (check mark). Fluorescent
proteins that do not bind to the DongleTrap remain cytoplasmic and are indicated by a cross. Insets show a 2× zoom of the indicated region of interest. Colored
bars above indicate the approximate emission of the fluorescent proteins tested.
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we expressed GFP–FKBP–TPD54 in HeLa cells either alone or
together with MitoTrap. Application of 200 nM rapamycin caused
the relocation of GFP–FKBP–TPD54 to mitochondria in seconds,
only when MitoTrap was present (Fig. 2A).
We wanted to use knocksideways on proteins that have a GFP
tag, but no FKBP. To enable this we designed a dongle comprising
three copies of FKBP fused to the N-terminus of GBPen, which
can be co-expressed in cells along with MitoTrap (see Materials
and Methods). When expressed transiently in cells along with
GFP–TPD54, application of rapamycin (200 nM) caused GFP–
TPD54 to become rapidly rerouted to mitochondria (Fig. 2A).
Mitochondrial rerouting was dependent on the presence of the dongle,
since no rerouting was seen in rapamycin-treated cells expressing
GFP–TPD54 and MitoTrap. The effect was indistinguishable from
Fig. 2. Dongles allow for knocksideways of GFP-tagged proteins that have no FKBP tag.Representative confocal images of live cells taken before (gray bar)
or after (orange bar) addition of 200 nM rapamycin. (A) GFP–FKBP–TPD54 or GFP–TPD54 were expressed in wild-type (WT) HeLa cells, along with
MitoTrap (pMito-mCherry-FRB) alone or together with the dongle as indicated. If MitoTrap (red in merge) was co-expressed, the red channel is shown in the inset
at half size. (B) In GFP–TPD54 knock-in HeLa cells, MitoTrap orMitoTrap+donglewere expressed as indicated. Scale bar: 10 µm. Schematic diagrams to the right
illustrate the experimental conditions and the respective result.
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rerouting of GFP–FKBP–TPD54 to MitoTrap in response to
rapamycin (Fig. 2A).
Given these encouraging results, we next tested whether
dongles could be used to reroute endogenous proteins, tagged
with GFP, to the mitochondria. To do this, we expressed the dongle
and MitoTrap in cells where endogenous TPD54 was tagged with
GFP (Larocque et al., 2019). We found that GFP–TPD54 was
rerouted when the dongle and MitoTrap were present and
rapamycin was added (Fig. 2B). Knocksideways was
qualitatively similar to GFP–FKBP–TPD54 or GFP–TPD54 and
dongle, expressed with MitoTrap in wild-type HeLa cells (Fig. 2).
These experiments indicate that the dongles can be used to extend
the function of GFP and to permit knocksideways experiments in
GFP knock-in cell lines without an FKBP tag. We termed this
method ‘dongle-knocksideways’.
Knocksideways of dynamin-2 in gene-edited human cells
We next wanted to use the dongle-knocksideways method to switch
off endocytosis on demand. A direct approach would be to
inactivate the large GTPase dynamin, which is essential for
vesicle scission during endocytosis (Antonny et al., 2016). We
therefore tested dongle-knocksideways in SK-MEL-2 hDNM2EN-all
cells, where both alleles of dynamin-2 are tagged with GFP (Doyon
et al., 2011). Confocal imaging revealed rapid and efficient
rerouting of dynamin-2–GFP (DNM2–GFP) to mitochondria
using 200 nM rapamycin in cells co-expressing the dongle and
MitoTrap (Fig. 3A; Movie 1).
The dongle used for knocksideways has three FKBP domains in
tandem, attached to GBPen (3×FKBP dongle). For reasons that will
become clear below, we also generated a dongle with a single FKBP
domain (1×FKBP dongle). Using this construct for dongle-
knocksideways of DNM2–GFP in SK-MEL-2 hDNM2EN-all cells
was similar to experiments that used 3×FKBP dongle (Fig. 3B).
Therefore, dynamin-2–GFP can be rerouted efficiently to
mitochondria using dongle-knocksideways.
Inhibition of clathrin-mediated endocytosis using dongles
Does dongle-knocksideways of dynamin-2–GFP cause an
inhibition of clathrin-mediated endocytosis (CME)? To answer
this question we analyzed the cellular uptake of fluorescently
labelled transferrin, an established assay for CME. We first verified
that chronic inhibition of CME could be achieved by expression of
DongleTrap (Fig. S1). Then we tested the effect of dongle-
knocksideways (rapamycin versus vehicle) and compared this to
inhibition of endocytosis (sucrose) using hypertonic media (Hansen
et al., 1993). To our surprise, we found that expression of the dongle
was sufficient to inhibit CME in SK-MEL-2 hDNM2EN-all cells
(Fig. 4). The amount of transferrin uptake in cells expressing
MitoTrap together with 3×FKBP dongle was significantly reduced
compared to untransfected cells or those expressing MitoTrap
alone (Fig. 4). This unintended inhibition of CME was
similar to treatment with hypertonic media, a classical method to
inhibit endocytosis. We wondered whether the size of 3×FKBP
dongle caused this inhibition and so we generated a 1×FKBP
dongle, which was approximately half the size (3×FKBP dongle,
49.8 kDa; 1×FKBP dongle, 25.9 kDa), and verified that the
1×FKBP dongle was fully functional for rerouting experiments
(Fig. 3B). Again, this dongle caused inhibition of CME by
expression in SK-MEL-2 hDNM2EN-all cells, similar to that
seen for 3×FKBP dongle (Fig. 4). Similar results were seen using
SK-MEL-2 hCLTAEN/hDNM2EN cells, which indicated that this
effect was not specific to the hDNM2EN-all cell line used (Fig. S2).
Note that with either dongle and either cell line, no further
inhibition of CME was observed by sucrose treatment nor by
rapamycin addition causing dongle-knocksideways. These
observations mean that the dongle method cannot be used in this
way to inhibit endocytosis on demand, since the active state is
inhibited unintentionally.
Our results suggested that the unintentional inhibition of CME
is caused by dongles binding to dynamin-2–GFP and inhibiting its
function. An alternative hypothesis is that the dongles inhibit
CME via some unknown mechanism and the effect in cells with
dynamin-2–GFP was coincidental. To test whether dongles
inhibited CME directly, we measured transferrin uptake in HeLa
cells with no dynamin-2–GFP, which expressed either the
3×FKBP or 1×FKBP dongles with MitoTrap (Fig. 5). We found
that transferrin uptake in these cells was similar to that in
cells expressing MitoTrap alone or to untransfected controls
(Fig. 5). CME in cells expressing either dongle could be inhibited
by sucrose and not by rapamycin treatment, which is to be
expected if there is no direct inhibition of CME caused by the
Fig. 3. Dongle-knocksideways efficiently reroutes dynamin-2–GFP to
mitochondria. Still confocal images from dongle-knocksideways experiments
showing a cell before and after application of 200 nM rapamycin. SK-MEL-2
hDNM2EN-all cells expressing GFP-tagged dynamin-2 (DNM2–GFP), MitoTrap
and either (A) 3×FKBP dongle or (B) 1×FKBP dongle. Scale bars: 10 µm.
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dongle. These experiments ruled out an inhibitory effect of
dongles on CME, and implicate the inhibition seen in cells
expressing dynamin-2–GFP as being due to binding of dynamin-
2–GFP with the nanobody.
UnintendedperturbationofGFP–TPD54 functionwithdongles
The dongle-mediated inhibition of dynamin-2–GFP function might
be particular to dynamin-2.We therefore tested whether the function
of GFP–TPD54 was also affected by dongle expression. TPD54 is
Fig. 4. Effect of dongle expression on transferrin uptake in SK-MEL-2 hDNM2EN-all cells. (A) Micrographs of SK-MEL-2 hDNM2EN-all cells treated with vehicle
(gray bar), sucrose (purple bar) or 200 nM rapamycin (orange bar). Cells were untransfected (No Dongle, No Mitotrap), or expressed MitoTrap alone, or MitoTrap
with 3×FKBP dongle or 1×FKBP dongle. DNM2–GFP (green), MitoTrap (red) and transferrin–Alexa Fluor 647 (TF647, blue) are displayed using the same
minimum andmaximum value per channel for all images in the figure. Scale bars: 10 µm. (B) Box plot to show quantification of transferrin uptake. Expression and
treatments are as indicated and colored as in A. Dots represent individual cells frommultiple experiments. Box represents the interquartile range (IQR), the line the
median and thewhiskers the 9th and 91st percentile. ncell=64–114, nexp=7. Two-way ANOVA on experimental means, within subject; Factor A=expression,DF=2,
F=12.44, Fc=8.77, P<0.001; Factor B=treatment, DF=3, F=35.02, Fc=7.05, P<0.001; A×B, DF=6, F=3.17, Fc=5.12, P<0.001. P-values from Dunnett’s post hoc
test are shown above each plot (Control vehicle as the control group).
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involved in anterograde traffic and its depletion results in delayed
transit of E-cadherin in a retention using selective hooks (RUSH)
assay (Larocque et al., 2019; Boncompain et al., 2012). In GFP–
TPD54 knock-in HeLa cells, we analysed the export of SBP–
mRuby2–E-cadherin from the ER to Golgi and on to the plasma
membrane using RUSH (Fig. 6). In cells that express dark MitoTrap
and 3×FKBP dongle, export from the ER to Golgi was significantly
faster compared to cells expressing dark MitoTrap alone (control)
(Fig. 6A–D). The kinetics of transport from the Golgi to the plasma
membrane were unaffected. These experiments indicate that
Fig. 5. Effect of dongle expression on transferrin uptake in HeLa cells. (A) Micrographs of HeLa cells treated with vehicle (gray bar), sucrose (purple bar) or
200 nM rapamycin (orange bar). Cells were untransfected (No Dongle, No Mitotrap), or expressed MitoTrap alone, or MitoTrap with 3×FKBP dongle or 1×FKBP
dongle. No GFP (green), MitoTrap (red) and transferrin–Alexa Fluor 647 (TF647, blue) are displayed using the same minimum and maximum value per
channel for all images in the figure. Scale bars: 10 µm. (B) Box plot to show quantification of transferrin uptake. Expression and treatments are as indicated and
colored as in A. Dots represent individual cells from a single experiment. Box represents the IQR, the line themedian and thewhiskers the 9th and 91st percentile.
One-way ANOVA P-values from Dunnett’s post hoc test are shown above each plot (Control vehicle as the control group).
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unintended perturbation of GFP-tagged protein function is not
particular to dynamin-2 but may be a general consequence of dongle
expression.
DISCUSSION
In this paper, we described the development of dongles to extend the
functionality of GFP for knocksideways experiments. We found that
these molecular tools were effective at binding GFP and permitting
the rerouting of the target protein to mitochondria. However, we
discovered an unintended side effect: dongles can perturb the
function of the GFP-tagged protein under study.
The use of GFP-binding proteins as an intracellular tool to
manipulate protein function is becoming widespread (Prole and
Taylor, 2019; Daniel et al., 2018; Ariotti et al., 2015). The appeal of
the method is that proteins tagged with GFP at their endogenous loci
can be adapted using dongles to enable inactivation, relocalization,
recoloring or other function. This means that existing cell lines or
organisms can be ‘retrofitted’ for additional functionality using such
tools. Indeed, our initial experiments using dongles were very
encouraging; the dongles expressed well, we detected no obvious
perturbation of subcellular distribution of the target proteins we
examined, and they permitted dongle-knocksideways which, in the
case of TPD54, was very similar to knocksideways (rerouting the
same protein with a fused GFP–FKBP tag). However, we found that
when the dongles were expressed in cells with both copies of
dynamin-2 tagged with GFP, endocytosis was inhibited. This
unintended effect seemed to be due to direct inhibition of dynamin
function following binding of dynamin-2–GFP by the nanobody
(GBPen) portion of the dongle. Dynamins may be uniquely
sensitive because they self-oligomerize, and we know that their
action can be readily inhibited by simple expression of a GTPase
deficient isoform (Damke et al., 1994). However, this problem was
not unique to dynamin-2 since we also saw that GFP–TPD54
function in anterograde traffic was perturbed by dongle expression.
We were fortunate to test this method on dynamin-2, which has a
clear functional readout as it controls the terminal step in clathrin-
mediated endocytosis (Antonny et al., 2016). Other proteins do not
have such unambiguous readouts, or their function can only be
measured indirectly, if at all. This would mean that if dongles were
used with these proteins, perturbed function would not be revealed
and potentially misleading conclusions drawn. This problem is
compounded because dongles would be most useful when applied
to proteins whose function is uncertain, so the perturbation of
protein function caused by these tools may be hidden from the
investigator. Our advice is that the same caution and functional tests
should be applied when using GFP nanobodies in cells as when
generating GFP-tagged proteins themselves (Snapp, 2005).
The mechanism of inhibition of dynamin-2–GFP function by
dongles is unclear. The simplest explanation is that extending the
GFP tag using a GFP nanobody plus additional domains results in a
modification that is simply too large for dynamin to function
normally; whether this is because of reduced dynamics, blocked
interactions or some other mechanism. We saw similar unintended
inhibition when the size of the dongle was reduced by half (from
three FKBP domains to one), suggesting that the binding of the
nanobody itself is inhibitory rather than there being a size limit to
the tag that dynamin-2 can tolerate. It is considered that most
proteins can tolerate the addition of GFP or GFP–FKBP tag, but it is
perhaps underappreciated that at some level, tags will always
interfere with protein function. The fact that we report perturbed
protein function using dongles is perhaps not surprising.
Unintended inhibition affects experiments where the protein of
interest needs to be functional (active) prior to inactivation. For other
applications of dongles, inhibitionmay not be such a concern. First, in
constitutive mislocalization experiments, where the goal is to
chronically inactivate protein function by changing its cellular
localization, dongles remain an important tool.We demonstrated here
the use of DongleTrap to inactivate dynamin-2–GFP. Second, it is
unclear whether labeling strategies based on dongles are
compromised by inhibition (Ariotti et al., 2015). We saw no
evidence of gross changes in subcellular localization of the two
proteins we tested; however, it remains questionablewhether imaging
a protein of interest in its inhibited state is representative of its normal
distribution. Third, in cases where investigators simply want to put a
functional domain to a new location using a GFP-tagged anchor
protein, such as calcium sensors at the endoplasmic reticulum (Prole
Fig. 6. Effect of dongle expression on
anterograde in GFP–TPD54 knock-in
HeLa cells. (A,B) Example trace of the
E-cadherin fluorescence ratio following
RUSH recorded from (A) a control (MitoTrap-
expressing, gray) or (B) a dongle (3×FKBP
dongle-expressing, green) GFP–TPD54
knock-in HeLa cell. Traces fitted with a
logistic function and a line. (C) Scaled
fraction of total E-cadherin fluorescence at
the Golgi as a function of time, in control
(gray) or dongle-expressing (green) cells.
Line and shaded area represent mean
±s.e.m. (D–F) Box plots showing the
half-times of E-cadherin transport from
(D) ER-to-Golgi and (E) ER-to-PM in control
and dongle-expressing GFP–TPD54
knock-in cells. (F) The difference in
half-times represents intra-Golgi transport.
Box represents the IQR, the line the median
and the whiskers the 9th and 91st percentile.
P-values from Student’s t-test with Welch’s
correction. ncell=49–82, nexp=3.
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and Taylor, 2019), inhibition of the anchor may not be a concern.
Fourth, our finding of nanobody-mediated inactivation of protein
function may even be useful as a general purpose method for
perturbing protein function in gene-edited cell lines.
What is the best strategy to extend the functionality of tags
introduced with knock-in technology? First, it may be possible to
reduce the inhibitory effect of dongles by mutating the GBP moiety
or using different domain configurations and/or by changing the
linker regions. Second, alternative GFP-binding proteins such as
those based on a designed ankyrin repeat protein (DARPin) scaffold
may be functionalized and used as dongles (Brauchle et al., 2014). It
is possible that these reagents do not have the same inhibitory
effects. Third, using split-GFP technology, proteins of interest could
be tagged with GFP11 and then the fluorescence complemented
with a GFP1-10 protein (Kamiyama et al., 2016), where GFP1-10 is
fused to other domains to extend the functionality. A further
advantage of this third method is that the fluorescence of the tagged
protein can also be altered during the complementation (Kamiyama
et al., 2016). However, a weakness is that this method would not
take advantage of existing GFP-tagged collections, and would
require new knock-ins to be generated in most cases. Finally, while
GBPen is the most widely used GFP nanobody, it is possible that
dongles that incorporate alternative GFP nanobodies may cause less
perturbation to target protein function.
MATERIALS AND METHODS
Molecular biology
Construction of plasmids to express GFP–TPD54 and GFP–FKBP–TPD54
and mCherry-MitoTrap (pMito-mCherry-FRB) was described previously
(Cheeseman et al., 2013; Larocque et al., 2019). The nanobody cDNA used
in this paper, described as GBPen (GFP-binding protein enhancer), was
synthesized from published sequences (Kubala et al., 2010; Kirchhofer
et al., 2010). To make pMito-mCherry-FRB-IRES-FKBP(III)-GBPen, a
bicistronic vector to co-express mCherry-MitoTrap and 3×FKBP–GBPen
via an internal ribosome entry site (IRES), a custom insert was made using
gene synthesis (GenScript) and inserted into pEGFP-C1 in place of GFP at
AgeI and EcoRI. A dark version of pMito-mCherry-FRB-IRES-FKBP(III)-
GBPen was also made by site-directed mutagenesis in mCherry to include
the K70N mutation. To express DongleTrap, pMito-GBPen was made by
amplifying GBPen from a plasmid containing FKBP(III)-GBPen (forward:
5′-cttaggatccggcaCAGGTGCAGCTG-3′, reverse:
5′-ggcctctagaTCAATGGTGATGGTG-3′) cloning into demethylated
pMito-mCherry-FRB using BamHI and XbaI. To make pMito-mCherry-
FRB-IRES-FKBP(I)-GBPen, the region of IRES including the HindIII cut
site and 1×FKBP was amplified using PCR from pMito-mCherry-FRB-
IRES-FKBP(III)-GBPen with addition of a BglII site at the end of the
amplified fragment (forward: 5′-GTTCCTCTGGAAGCTTCTTGAAG-3′,
reverse: 5′-gcgagatctTTCCAGTTTTAGAAGCTCCACATC-3′). The
product was cut with HindIII and BglII. The same vector was cut with
HindIII and BglII, resulting in a vector lacking all three FKBP tags. The cut
PCR product was ligated back into the cut vector. pMito-mCherry-FRB-
IRES-FKBP(I)-GBPen, pMito-mCherry-FRB-IRES-FKBP(III)-GBPen
and pMito-GBPen were deposited to Addgene as #128267, #128268,
#128269, respectively. To make Str-KDEL-SBP-mRuby2-E-Cadherin, the
FastCloning technique was used (Li et al., 2011). Briefly, EGFP was
removed from the original RUSH construct Str-KDEL-SBP-EGFP-E-Ca-
dherin (Boncompain et al., 2012) by amplifying the plasmid from either side
of EGFP with the following primers: forward: 5′-GGACGAGCTGTACA-
AGGGccggCCAgactgggtc-3′ and reverse: CGCCCTTAGACACCATAC-
CtgcaggTGGTTCACGTTG-3′. mRuby2 was amplified using mRuby2-N1
(Addgene, #54614) with the following primers: forward: 5′-GAACCAcct-
gcaGGTATGGTGTCTAAGGGCGAAGAG-3′ and reverse: 5′-ccagtcTG-
GccggCCCTTGTACAGCTCGTCCATCCC-3′. Both amplicons have
overlapping sequences. The insert and the vector were then digested with
DpnI and transformed in DH5α cells.
Plasmids to express fluorescent proteins were either available from
previous work: pDsRed-N1, pEGFP-N1, pECFP-N1, pEYFP-N1, pmRFP-
N1, pmCherry-N1, pTagBFP2; from Addgene: pmScarlet-C1 (#85042),
pTagRFP657-N1 (#44275), psfGFP-N1 (#54737), pEBFP2-N1 (#54595),
mAzurite-N1 (#54617), mCerulean3-N1 (#54730), mTurquoise2-N1
(#60561), mVenus-N1 (#27793), mRuby2-N1 (#54614), mNeptune2-N1
(#54837), mOrange2-N1 (#54499), mCitrine2-N1 (#54594), mEmerald-N1
(#53976), pcDNA3-Clover (#40259), mAzamiGreen-N1 (#54798),
mMaroon-N1 (#54554), mKO2-N1 (#54625); or from Allele Biotech:
pmNeonGreen-N1 (ABP-FP-MNEONSA).
Cell biology
HeLa cells (HPA/ECACC #93021013) or GFP–TPD54 knock-in HeLa cells
(Larocque et al., 2019) were cultured in DMEM+GlutaMAX (Thermo
Fisher) supplemented with 10% fetal bovine serum, and 100 U ml−1
penicillin/streptomycin. SK-MEL-2 hDNM2EN-all or hDNM2EN-all/
CLTAEN cells (a kind gift from David Drubin, Department of Molecular
and Cellular Biology, University of California Berkeley, CA) were cultured
in Dulbecco’s modified Eagle’s medium or nutrient mixture F-12 Ham
(Sigma-Aldrich) supplemented with 10% fetal bovine serum, 1% L-
glutamine, 3.5% sodium bicarbonate and 100 U ml−1 penicillin/
streptomycin. All cells were kept at 37°C and 5% CO2. HeLa cells were
transfected with 1.2 µg DNA (total) per 3 µl GeneJuice (Merck Millipore)
according to the manufacturer’s instructions. SK-MEL-2 cells were
transfected with 4.8 µg DNA (total) per 850,000 cells using Neon
Transfection System (Thermo Fisher) with three pulses of 1500 V, 10 ms.
Cells were analyzed 2 days post-transfection.
Transferrin uptake experiments were as described previously (Clarke and
Royle, 2018). Briefly, cells were serum-starved for 30 min. For
knocksideways, they were exposed to 200 nM rapamycin (Alfa Aesar) or
0.1% ethanol (vehicle) for the last 10 min of starvation, and then incubated
with 100 µg/ml Alexa Fluor 647-conjugated transferrin (Invitrogen) for
10 min. Hypertonic sucrose media (0.45 M) was used to inhibit transferrin
uptake. All incubations were in serum-free media at 37°C with 5% CO2 in a
humidified incubator. Cells were then fixed in 3% PFA/4% sucrose in PBS
and mounted on slides using Mowiol.
Microscopy
For live-cell imaging of rerouting experiments, cells were grown in 4-well
glass-bottom 3.5 cm dishes (Greiner Bio-One) and media exchanged for
Leibovitz L-15 CO2-independent medium. Rerouting was triggered by
addition of 200 nM rapamycin in L-15 media.
For the RUSH assay, GFP–TPD54 knock-in HeLa cells were transfected
with Str-KDEL-SBP-mRuby2-E-Cadherin and either darkMitoTrap (Wood
et al., 2017) alone or a plasmid that expressed 3×FKBP dongle and dark
MitoTrap coupled by an IRES. mRuby2–E-cadherin was released from the
ER by adding a final concentration of 40 µM D-Biotin (Sigma-Aldrich) in
L-15 medium. Images were captured at a time interval of 2 min.
All cells were imaged at 37°C on a spinning disc confocal system
(Ultraview Vox, PerkinElmer) with a 100×1.4 NA oil-immersion objective.
Images were captured using an ORCA-R2 digital CCD camera
(Hamamatsu) following excitation with 488 nm and 561 nm lasers.
Imaging of fixed cells was done on a Nikon Ti-U epiflorescence
microscope with 100× oil-immersion objective, CoolSnap MYO camera
(Photometrics) using NIS-Elements software (Nikon).
Data analysis
Analysis of transferrin uptake was done as described previously (Wood
et al., 2017). Briefly, single cells were outlined manually in Fiji. Vesicular
structures were isolated by applying a manual threshold to images in the
transferrin channel. Positive structures were counted using ‘Analyze
particles’, with limits of 0.03–0.8 µm and circularity of 0.3–1.0. All
analysis was done with the experimenter blind to the conditions of the
experiment.
Analysis of RUSH experiments was done as previously described
(Larocque et al., 2019), using custom-written code (https://doi.org/10.5281/
zenodo.3366083).
8
TOOLS AND RESOURCES Journal of Cell Science (2019) 132, jcs234955. doi:10.1242/jcs.234955
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Figures were made with Fiji or Igor Pro 8 (WaveMetrics), and assembled
using Adobe Illustrator. Null hypothesis statistical tests were done as
described in the figure legends.
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